| 000 | 01760 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515004910.0 | ||
| 264 | 0 | _c20060117 | |
| 008 | 200601s 0 0 eng d | ||
| 022 | _a1526-8209 | ||
| 024 | 7 |
_a10.3816/CBC.2005.n.035 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGarcía-Sáenz, José A | |
| 245 | 0 | 0 |
_aTrastuzumab associated with successive cytotoxic therapies beyond disease progression in metastatic breast cancer. _h[electronic resource] |
| 260 |
_bClinical breast cancer _cOct 2005 |
||
| 300 |
_a325-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBone Neoplasms _xsecondary |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGenes, erbB-2 _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 |
_aSoft Tissue Neoplasms _xsecondary |
| 650 | 0 | 4 |
_aTaxoids _xadministration & dosage |
| 650 | 0 | 4 | _aTrastuzumab |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVinblastine _xadministration & dosage |
| 650 | 0 | 4 | _aVinorelbine |
| 700 | 1 | _aMartín, Miguel | |
| 700 | 1 | _aPuente, Javier | |
| 700 | 1 | _aLópez-Tarruella, Sara | |
| 700 | 1 | _aCasado, Antonio | |
| 700 | 1 | _aMoreno, Fernando | |
| 700 | 1 | _aGrande, Enrique | |
| 700 | 1 | _aDíaz-Rubio, Eduardo | |
| 773 | 0 |
_tClinical breast cancer _gvol. 6 _gno. 4 _gp. 325-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3816/CBC.2005.n.035 _zAvailable from publisher's website |
| 999 |
_c15902817 _d15902817 |
||